Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma.

[1]  M. Kohonen-Corish,et al.  Low microsatellite instability is associated with poor prognosis in stage C colon cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. McLendon,et al.  Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Kirkwood,et al.  Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? , 2004, European journal of cancer.

[4]  D. Morton,et al.  Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients , 2004, Oncogene.

[5]  J. Thompson.  Surgical treatment of systemic metastases : rationale and principles , 2004 .

[6]  S. Ma,et al.  O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma , 2003, British Journal of Cancer.

[7]  B. Leggett,et al.  The impact of microsatellite instability on the molecular phenotype of colorectal tumors. , 2003, Cancer research.

[8]  G. Botti,et al.  Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases , 2003, Melanoma research.

[9]  S. Goodman,et al.  Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  S. Groshen,et al.  Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  L. Aaltonen,et al.  Does MSI‐low exist? , 2002, The Journal of pathology.

[12]  S. Goodman,et al.  Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. , 2002, Journal of the National Cancer Institute.

[13]  W. Stolz,et al.  Microsatellite instability in malignant melanomas. , 2001, Acta dermato-venereologica.

[14]  R. Mariani-Costantini,et al.  Instability at sequence repeats in melanocytic tumours , 2001, Melanoma research.

[15]  B. Leggett,et al.  Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. , 2001, Cancer research.

[16]  G. Botti,et al.  Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases , 2000, British Journal of Cancer.

[17]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[18]  X. Estivill,et al.  Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases , 2000, Melanoma research.

[19]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[20]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[21]  J. Rüschoff,et al.  Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.

[22]  M. Loda,et al.  Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. , 1997, Cancer research.

[23]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Bodmer,et al.  Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. , 1996, European journal of cancer.

[25]  H. Kerl,et al.  Microsatellite instability and loss of heterozygosity in melanoma. , 1995, The Journal of investigative dermatology.

[26]  E. Healy,et al.  Microsatellite instability in human non-melanoma and melanoma skin cancer. , 1995, The Journal of investigative dermatology.

[27]  M. Dolan,et al.  Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. , 1990, Proceedings of the National Academy of Sciences of the United States of America.